BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 3547024)

  • 21. Macrophage-directed lymphokines.
    Liu DY
    Surv Immunol Res; 1984; 3(2-3):154-60. PubMed ID: 6426009
    [No Abstract]   [Full Text] [Related]  

  • 22. Activation of tumoricidal and/or suppressor macrophages: different stimulatory signals trigger either function both in vivo and in vitro.
    Taramelli D; Bagley MB; Holden HT; Varesio L
    Adv Exp Med Biol; 1982; 155():487-92. PubMed ID: 6218736
    [No Abstract]   [Full Text] [Related]  

  • 23. Activation of macrophages by lymphokines from T-cell clones: evidence for different macrophage-activating factors.
    Gemsa D; Kubelka C; Debatin KM; Krammer PH
    Mol Immunol; 1984 Dec; 21(12):1267-76. PubMed ID: 6395005
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activation of tumoricidal properties in macrophages by lymphokines encapsulated in liposomes.
    Fidler IJ; Fogler WE
    Lymphokine Res; 1982; 1(3):73-7. PubMed ID: 6765335
    [No Abstract]   [Full Text] [Related]  

  • 25. Effect of inoculation with neuraminidase-treated tumor cells on macrophage cytotoxicity in vitro.
    Alley CD; Snodgrass MJ
    Cancer Res; 1978 Aug; 38(8):2332-8. PubMed ID: 667829
    [No Abstract]   [Full Text] [Related]  

  • 26. Activation of macrophage tumor cytotoxicity by the synergism of two T cell-derived lymphokines: immune interferon (IFN-gamma) and macrophage cytotoxicity-inducing factor 2 (MCIF2).
    Hamann U; Krammer PH
    Eur J Immunol; 1985 Jan; 15(1):18-24. PubMed ID: 3917924
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Augmentation of the adoptive transfer of specific tumor immunity by non-specifically immunized macrophages.
    Ariyan S; Gershon RK
    J Natl Cancer Inst; 1973 Oct; 51(4):1145-8. PubMed ID: 4583372
    [No Abstract]   [Full Text] [Related]  

  • 28. Involvement of the omental lymphoid organ in the induction of peritoneal immunity against tumor cells.
    Dullens HF; Rademakers LH; Doffemont M; Van Veen PT; Bulder R; Den Otter W
    Invasion Metastasis; 1993; 13(5):267-76. PubMed ID: 7960579
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Down regulation of RNA labeling as a selective marker for cytotoxic but not suppressor macrophages.
    Varesio L
    J Immunol; 1984 Jun; 132(6):2683-5. PubMed ID: 6202756
    [No Abstract]   [Full Text] [Related]  

  • 30. The capacity of activated murine macrophages for augmented binding of neoplastic cells: analysis of induction by lymphokine containing MAF and kinetics of the reaction.
    Marino PA; Adams DO
    J Immunol; 1982 Jun; 128(6):2816-23. PubMed ID: 6804569
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Macrophage activation for tumor cytotoxicity: tumoricidal activity by macrophages from C3H/HeJ mice requires at least two activation stimuli.
    Ruco LP; Meltzer MS
    Cell Immunol; 1978 Nov; 41(1):35-51. PubMed ID: 363288
    [No Abstract]   [Full Text] [Related]  

  • 32. Lipopolysaccharide-induced immunomodulation of the generation cell-mediated cytotoxicity. II. Evidence for the involvement of a regulatory B lymphocyte.
    Vallera DA; Gamble CE; Schmidtke JR
    J Immunol; 1980 Feb; 124(2):641-9. PubMed ID: 6444315
    [No Abstract]   [Full Text] [Related]  

  • 33. Identification of macrophage-mediated cytolytic activity as a tumor suppressive mechanism during maintenance of the L5178Y-tumor dormant state in DBA/2 mice.
    Robinson MK; Wheelock EF
    J Immunol; 1981 Feb; 126(2):673-9. PubMed ID: 7451990
    [No Abstract]   [Full Text] [Related]  

  • 34. Macrophage activation for tumor cytotoxicity: development of macrophage cytotoxic activity requires completion of a sequence of short-lived intermediary reactions.
    Ruco LP; Meltzer MS
    J Immunol; 1978 Nov; 121(5):2035-42. PubMed ID: 712076
    [No Abstract]   [Full Text] [Related]  

  • 35. Synergistic cytolytic activity by combined populations of peritoneal T lymphocytes and macrophages during the L5178Y cell tumor-dormant state in DBA/2 mice.
    Robinson MK; Wheelock EF
    Cell Immunol; 1982 Nov; 73(2):230-46. PubMed ID: 6984360
    [No Abstract]   [Full Text] [Related]  

  • 36. Macrophage activation for tumor cytotoxicity: increased lymphokine responsiveness of peritoneal macrophages during acute inflammation.
    Ruco LP; Meltzer MS
    J Immunol; 1978 Mar; 120(3):1054-62. PubMed ID: 632578
    [No Abstract]   [Full Text] [Related]  

  • 37. Rapid decay of tumoricidal activity and loss of responsiveness to lymphokines in inflammatory macrophages.
    Poste G; Kirsh R
    Cancer Res; 1979 Jul; 39(7 Pt 1):2582-90. PubMed ID: 87267
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Macrophage tumor cells can help to cure murine lymphoma.
    Van Loveren H; De Groot JW; Den Otter W
    Proc Soc Exp Biol Med; 1981 Jun; 167(2):207-11. PubMed ID: 6972046
    [No Abstract]   [Full Text] [Related]  

  • 39. The role of macrophages in the cytotoxic killing of tumour cells in vitro. I. Primary immunization of lymphocytes in vitro for target cell killing and the mechanism of lymphocyte-macrophage cooperation.
    Zembala M; Ptak W; Hanczakowska M
    Immunology; 1973 Oct; 25(4):631-44. PubMed ID: 4356674
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cell-mediated cytotoxic responses induced in vivo and in vitro by a metastatic murine tumor.
    Wiltrout RH; Frost P
    J Immunol; 1980 May; 124(5):2254-63. PubMed ID: 7365255
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.